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Background: The incidence of diastolic dysfunction increases with age and menopause. It may further lead to heart failure due to delayed 
filling of the left ventricle (LV) secondary to abnormalities in LV relaxation. Removal of ovarian hormones increases LV remodeling in aged rats and 
hormone replacement therapy attenuates the development of LV hypertrophy in hypertensive postmenopausal women. It remains unclear whether 
commencement of estrogen therapy at menopause preserves lusitropic function.
Methods: Using conventional and tissue Doppler imaging, diastolic function was compared between middle-aged ovariectomized (OVX, n = 12) 
and estrogen-replaced (human equivalent dose of 1 mg estradiol/day) (OVX+E2, n = 11) cynomolgus monkeys during isoflurane (1.5%) anesthesia.
Results: Body weight, blood pressure, heart rate, fractional shortening, and septal wall thicknesses were similar between groups following eight 
months of estradiol replacement therapy. Mitral early and late inflow velocities were 57% and 51% higher, respectively, and the deceleration time 
of the mitral E wave was 19 % lower in estrogen-replete compared to OVX monkeys (P<0.05). Despite similar Doppler-derived LV filling pressures 
(E/e′), estrogen treated monkeys had higher mitral annular velocities (e′) (OVX+E2: 5.24 ± 0.27 vs. OVX: 3.41 ± 0.37 cm/s, P<0.001) and greater 
changes in ascending aorta internal diameter during the cardiac cycle (OVX+E2: 0.090 ± 0.012 vs. OVX: 0.064 ± 0.004 cm, P<0.05) than untreated, 
OVX monkeys.
Conclusions: In conclusion, our study is supportive of a role for early physiologic estrogen replacement therapy in the prevention of 
postmenopausal diastolic dysfunction via its direct lusitropic benefits and/or through estrogen mediated-improvements in vascular hemodynamics.
